Scientists evaluated the efficacy and safety of venetoclax plus azacitidine and donor lymphocyte infusion in treating patients with relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.
[Annals of Hematology]
7992332
{7992332:AAAAAAAA}
apa
50
1
167313
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
